GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Short-Term Debt

CVALF (Covalon Technologies) Short-Term Debt : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Short-Term Debt?

Covalon Technologies's Short-Term Debt for the quarter that ended in Dec. 2024 was $0.00 Mil.


Covalon Technologies Short-Term Debt Historical Data

The historical data trend for Covalon Technologies's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Short-Term Debt Chart

Covalon Technologies Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.40 - - - -

Covalon Technologies Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Covalon Technologies Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Covalon Technologies Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes and save lives in the areas of infection management, wound care, and surgical procedures. The company generates its revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products are CovaClear, IV IV Clear, SurgiClear, and VALGuard.